Merck KGaA CFO Helene von Roeder discusses the group's third-quarter earnings and its progress with drug trials.

Merck , known as MSD outside of the United States and Canada, and LaNova Medicines Ltd. (LaNova), a privately held clinical-stage biotechnology company, today announced that Merck has entered into an ...

Each year, 500 to 1,000 people in the U.S. are diagnosed with pulmonary arterial hypertension (PAH), a progressive and often under-detected disease. To address the significant impact of this disease ...

US stock futures edged higher Thursday ahead of a highly-anticipated speech by Fed chair Jerome Powell, which could provide ...

It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector ...

Here's why the Vanguard Utilities ETF (NYSEMKT: VPU), Vanguard Consumer Staples ETF (NYSEMKT: VDC), and Vanguard Health Care ...

I’ve probably [examined] over 1000 patients suspecting of it ... the vertical of the bridge. For example, Merck [& Co.] has ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

Alphabet's Q3 results show strong revenue and operating income growth, but declining free cash flow. Read why I think GOOG ...

Shipping giant CMA CGM has asked its customers to be ready with the additional mandatory data required to be provided under the European Unions’ Import Control System 2 (ICS2) regulations, to ...

For comparison, only 72% of the stocks in the Russell 1000 Value Index, this fund’s large-value category benchmark, paid dividends. The FTSE High Dividend Yield Index has 450 stocks, and true to ...